FDA Recommends Precautionary Language On Neuropsychiatric Events For Tamiflu
This article was originally published in The Pink Sheet Daily
Executive Summary
Agency’s Pediatric Advisory Committee will also evaluate updated adverse event data from the 2006-2007 flu season for GSK’s Relenza.